WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company

This week’s episode of “WisBusiness: the Podcast” is with Serafino Fabiano, associate vice president and site lead for Eli Lilly and Company’s Kenosha facility.

After the company acquired the property in 2024, the pharmaceutical company announced plans for a $4 billion investment in Wisconsin for the injectable medicine production site.

“In 18 months, we were able to move from the acquisition to the FDA approval and make medicine for our patients,” Fabiano said. “And I would say that the best is yet to come. If you drive by our site you will see cranes still being raised, so definitely exciting times ahead for Lilly Kenosha, our patients and our community.”

Click here to read full article.